Fate Therapeutics Inc. diskutieren
Fate Therapeutics Inc.
WKN: A1W50M / Symbol: FATE / Name: Fate / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
SecteurRecherche biotechnologique et médicale Agenda 10/05 Publication de résultats
Nombre d'employés
: 80 personnes
marge stimmt der Buy-Einschätzung der Analysten zu
Piper Jaffray is reissuing its Buy rating on Fate Therapeutics (FATE) today, but lifting its price target seven bucks a share to $30. Piper's analyst states 'the company remains a top pick for the second half of 2019 given its "first-in-class iPSC cancer cell pipeline'.
Neueste Beiträge
Vassago1 in Fate Therapeutics Inc. diskutieren